A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Remibrutinib in Patients With Secondary Progressive Multiple Sclerosis
NCT07225504 · RECRUITING · Phase 3
ReadTheTrial indexes 2 studies for Secondary Progressive Multiple Sclerosis Spms. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
2 clinical trials found for Secondary Progressive Multiple Sclerosis Spms.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 3 | 1 | 50% |
| Phase 2 | 1 | 50% |
There are 2 clinical trials listed for Secondary Progressive Multiple Sclerosis Spms. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Secondary Progressive Multiple Sclerosis Spms trials are distributed across: Phase 3 (1), Phase 2 (1).